Stevanato Group SpA
STVN15.500USD
+1.350+9.54%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
4.23BMarktkapitalisierung
35.26KGV TTM
mehr Informationen über Stevanato Group SpA Unternehmen
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
Stevanato Group SpA Informationen
BörsenkürzelSTVN
Name des UnternehmensStevanato Group SpA
IPO-datumJul 16, 2021
CEOStevanato (Franco)
Anzahl der mitarbeiter5521
WertpapierartOrdinary Share
GeschäftsjahresendeJul 16
AddressePiombino Dese (Pd) Via Molinella, 17
StadtPIOMBINO DESE
BörseNASDAQ OMX NASDAQ Basic NYSE
LandItaly
Postleitzahl35017
Telefon390499318173
Websitehttps://www.stevanatogroup.com/
BörsenkürzelSTVN
IPO-datumJul 16, 2021
CEOStevanato (Franco)
Führungskräfte von Stevanato Group SpA
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Mauro Stocchi
Mr. Mauro Stocchi
Chief Business Officer
Chief Business Officer
415.36K
+2470.00%
Mr. Fabrizio Bonanni
Mr. Fabrizio Bonanni
Independent Director
Independent Director
119.70K
-26933.00%
Mr. Madhavan (Madhu) Balachandran
Mr. Madhavan (Madhu) Balachandran
Independent Director
Independent Director
63.70K
+5598.00%
Mr. William J. (Bill) Federici, CPA
Mr. William J. (Bill) Federici, CPA
Independent Director
Independent Director
52.82K
+5598.00%
Mr. Riccardo Butta
Mr. Riccardo Butta
President, Americas
President, Americas
30.13K
+30129.00%
Mr. Alvise Spinazzi
Mr. Alvise Spinazzi
Director
Director
3.30K
--
Mr. Fabio Buttignon, CPA
Mr. Fabio Buttignon, CPA
Independent Director
Independent Director
--
--
Dr. Donald E. (Don) Morel, Jr.
Dr. Donald E. (Don) Morel, Jr.
Independent Director
Independent Director
--
--
Mr. Franco Moro
Mr. Franco Moro
Director
Director
--
--
Mr. Marco Dal Lago
Mr. Marco Dal Lago
Chief Financial Officer
Chief Financial Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Mauro Stocchi
Mr. Mauro Stocchi
Chief Business Officer
Chief Business Officer
415.36K
+2470.00%
Mr. Fabrizio Bonanni
Mr. Fabrizio Bonanni
Independent Director
Independent Director
119.70K
-26933.00%
Mr. Madhavan (Madhu) Balachandran
Mr. Madhavan (Madhu) Balachandran
Independent Director
Independent Director
63.70K
+5598.00%
Mr. William J. (Bill) Federici, CPA
Mr. William J. (Bill) Federici, CPA
Independent Director
Independent Director
52.82K
+5598.00%
Mr. Riccardo Butta
Mr. Riccardo Butta
President, Americas
President, Americas
30.13K
+30129.00%
Mr. Alvise Spinazzi
Mr. Alvise Spinazzi
Director
Director
3.30K
--
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Revenues from high-value solutions
147.94M
48.80%
Revenues from other containment and delivery solutions
118.81M
39.19%
Revenues from engineering
36.42M
12.01%
Nach RegionUSD
Name
Umsatz
Anteil
EMEA
175.50M
57.89%
North America
93.48M
30.84%
APAC
24.93M
8.22%
South America
9.25M
3.05%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Revenues from high-value solutions
147.94M
48.80%
Revenues from other containment and delivery solutions
118.81M
39.19%
Revenues from engineering
36.42M
12.01%
Aktionärsstatistik
Aktualisiert: 2 hours ago
Aktualisiert: 2 hours ago
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Conestoga Capital Advisors, LLC
15.87%
Neuberger Berman, LLC
9.98%
T. Rowe Price Investment Management, Inc.
7.15%
TimesSquare Capital Management, LLC
7.04%
Thrivent Asset Management, LLC
4.74%
Andere
55.21%
Aktionäre
Aktionäre
Anteil
Conestoga Capital Advisors, LLC
15.87%
Neuberger Berman, LLC
9.98%
T. Rowe Price Investment Management, Inc.
7.15%
TimesSquare Capital Management, LLC
7.04%
Thrivent Asset Management, LLC
4.74%
Andere
55.21%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor/Hedge Fund
52.69%
Investment Advisor
49.53%
Research Firm
2.44%
Sovereign Wealth Fund
2.18%
Individual Investor
1.61%
Hedge Fund
1.34%
Pension Fund
0.84%
Bank and Trust
0.83%
Family Office
0.19%
Institutionelle Beteiligung
Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
348
53.34M
107.30%
-15.50M
2025Q3
347
55.80M
112.27%
-10.59M
2025Q2
366
55.23M
111.34%
-15.05M
2025Q1
376
57.92M
116.77%
-13.37M
2024Q4
358
58.53M
118.10%
-12.44M
2024Q3
347
57.73M
116.49%
-11.43M
2024Q2
334
55.33M
111.66%
-5.97M
2024Q1
321
56.90M
119.64%
+12.26M
2023Q4
299
39.58M
111.81%
-6.75M
2023Q3
276
37.46M
106.70%
-5.32M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Conestoga Capital Advisors, LLC
8.09M
16.28%
-29.80K
-0.37%
Sep 30, 2025
Neuberger Berman, LLC
4.96M
9.98%
+86.56K
+1.78%
Nov 30, 2025
T. Rowe Price Investment Management, Inc.
3.55M
7.15%
-180.57K
-4.83%
Sep 30, 2025
TimesSquare Capital Management, LLC
3.27M
6.57%
-57.86K
-1.74%
Sep 30, 2025
Thrivent Asset Management, LLC
2.37M
4.77%
+156.73K
+7.07%
Sep 30, 2025
Artisan Partners Limited Partnership
2.61M
5.26%
-120.54K
-4.41%
Sep 30, 2025
Baron Capital Management, Inc.
1.97M
3.97%
+85.71K
+4.54%
Sep 30, 2025
Jennison Associates LLC
1.56M
3.14%
+473.78K
+43.65%
Sep 30, 2025
ArrowMark Colorado Holdings, LLC
1.39M
2.8%
+86.97K
+6.66%
Sep 30, 2025
Pembroke Management Ltd.
1.28M
2.58%
+136.71K
+11.92%
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
First Trust IPOX Europe Equity Opportunities ETF
1.39%
Neuberger Berman Small-Mid Cap ETF
1.39%
State Street SPDR S&P Kensho New Econ Comp ETF
0.22%
iShares Biotechnology ETF
0.11%
Goldman Sachs MarketBeta International Equity ETF
0%
BNY Mellon International Equity ETF
0%
Goldman Sachs MarketBeta Total Internatl Eqty ETF
0%
Goldman Sachs Future Health Care Equity ETF
0%
iShares Disciplined Volatility Equity Active ETF
0%
First Trust IPOX Europe Equity Opportunities ETF
Anteil1.39%
Neuberger Berman Small-Mid Cap ETF
Anteil1.39%
State Street SPDR S&P Kensho New Econ Comp ETF
Anteil0.22%
iShares Biotechnology ETF
Anteil0.11%
Goldman Sachs MarketBeta International Equity ETF
Anteil0%
BNY Mellon International Equity ETF
Anteil0%
Goldman Sachs MarketBeta Total Internatl Eqty ETF
Anteil0%
Goldman Sachs Future Health Care Equity ETF
Anteil0%
iShares Disciplined Volatility Equity Active ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
53.45M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
May 02, 2025
STVN.NB Final Cash Dividend of gross EUR 0.054 paid on Jul 17, 2025 going ex on Jun 05, 2025
Jun 05, 2025
Jul 17, 2025
Jun 05, 2025
May 31, 2024
STVN.NB Final Cash Dividend of gross EUR 0.053 paid on Jul 15, 2024 going ex on Jun 04, 2024
Jun 04, 2024
Jul 15, 2024
Jun 04, 2024
Jun 06, 2023
STVN.NB Final Cash Dividend of gross EUR 0.054 paid on Jul 17, 2023 going ex on Jun 07, 2023
Jun 06, 2023
Jul 17, 2023
Jun 07, 2023
Jun 08, 2022
STVN.NB Final Cash Dividend of gross EUR 0.051 paid on Jul 13, 2022 going ex on Jun 13, 2022
Jun 14, 2022
Jul 13, 2022
Jun 13, 2022
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
